Because tirzepatide activates GIP receptors in addition to GLP-1 receptors, you get an entirely separate signaling pathway
If you are eager to try a new oral GLP-1, the most practical path right now is to ask your prescriber to document your medical necessity clearly and flag it for a coverage review with your insurer as formularies update
The cost savings from overseas suppliers often disappear when accounting for these factors
The currently recommended pharmacological treatments for DPN mainly include antidepressants due to their analgesic effects, while a strategy for the pathogenesis and progression of DPN is lacking
If retatrutide is approved in the future, switching would be a clinical decision based on your individual response, side effects, cardiovascular risk profile, and access
Patients with sensitive stomachs or history of nausea often benefit from starting at 2.4 mg rather than jumping to 5 mg immediately